| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/03/23 | 8-K | Current report filing |
|
   |
100 |
| 10/02/23 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
39 | |
| 09/18/23 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 08/28/23 | 8-K | Current report filing |
|
|
3 |
| 08/23/23 | DEF 14A | Definitive proxy statements |
|
20 | |
| 08/09/23 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
18 | |
| 07/28/23 | 8-K | Current report filing |
|
|
4 |
| 07/25/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/25/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/25/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.